Inotiv, Inc. — M&A Activity 2003

Jul 1, 2003

8-K 1 basform8k.htm BIOANALYTICAL SYSTEMS, INC. Bioanalytical Systems, Inc. - Form 8K

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549

FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported): June 30, 2003

BIOANALYTICAL SYSTEMS, INC. (Exact name of registrant as specified in its charter)

Indiana	0-23357	35-1345024
(State or other jurisdiction of incorporation or organization)	(Commission File Number)	(IRS Employer Identification No.)
2701 Kent Avenue West Lafayette, IN		47906-1382
(Address of principal executive offices)		(Zip Code)
	(765) 463-4527
	(Registrant's telephone number, including area code)

Item 5.

On July 1, 2003, Bioanalytical Systems, Inc. (the "Company") issued the press release filed herewith as Exhibit 99.1, and incorporated herein by reference, announcing the completion of its acquisition of PharmaKinetics Laboratories, Inc.

Item 7. Financial Statements and Exhibits.

The following exhibits are filed as a part of this report:

(c) Exhibits

99.1 Press release, dated July 1, 2003, announcing the completion its acquisition of PharmaKinetics Laboratories, Inc.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation"

Date: July 1, 2003 BIOANALYTICAL SYSTEMS, INC. (Registrant) By: /s/ Douglas P. Wieten Douglas P. Wieten Vice President - Finance, Chief Financial Officer and Treasurer

Exhibit Index

MARKER FORMAT-SHEET="Exhibit Header" FSL="Workstation"

Item Number assigned in Regulation S-K Exhibit Description of Exhibits

MARKER FORMAT-SHEET="Exhibit List" FSL="Workstation"

99 (99.1) Press release dated July 1, 2003.